Japan In Vitro Diagnostics (IVD) Market, By Diagnostics (Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring of Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Roche Diagnostics, Biomerieux, Abbott Laboratories & Danaher Corporation), Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities
In Japan In vitro Diagnostic comes under medical device, which is consumable or disposable and used to collect numerous bio-samples under various medical conditions. According to Renub Research Japan In vitro Diagnostics market is expected to surpass US$ 4.3 Billion by the end of year 2024.
Ageing Population will Foster the Growth of Japan In vitro Diagnostics Market
Japan has highest proportion of ageing population globally; almost its quarter of population is 65+ age. Rise in number of ageing population is the biggest burden for Japanese government because prevalence of ageing disease rising at rapid pace. So Japanese government has given priority to deal with ageing population and it is expected that government will allocate skyrocket healthcare budget in 2025 for ageing. Therefore rising prevalence and increased public expenditure will boost the Japan In Vitro Diagnostics Market in future.
Pathology Market is the Fastest Growing Segment in Japan In-vitro Diagnostics Market
In this report Renub Research has done in-depth study of 11 segments of Japan In-vitro Diagnostic Market: Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology, Genetic Testing and Others. The report gives you comprehensive insight of each segment of In-vitro diagnostic along with separate growth factors for each of segments.
Positive Reimbursement Policy will further boost the Market of Japan In-vitro Diagnostics Market
This report by Renub Research explains length and breadth of reimbursement policies along with complete framework. It also provides clear insight & structure of how it works actually, how to take approval from Japanese authorities regarding reimbursement policies. It explains classification of medical devices in Japan and which class In vitro diagnostic fits. It covers all medical manufacturer applied for reimbursement approval in Japan for past five years.
Continuous Advancement of Diagnostic Technology & non-invasive Technique will improve the Growth of Japan In-vitro Diagnostics Market
The advancement in In vitro Diagnostic technique has made it simpler to diagnose with lesser time being less invasive. The improved digitization in pathology has gain the ability to deliver the clinical outcome within the stipulated time-frame. Japan has successfully done the trial for first urine test to diagnose cancer in the world in 2018. Moreover for colon cancer, screening is conducted via a feces test. All these technology improvement will further enhance the Japan In vitro Diagnostic market.
In this report, we have covered the most important section Market Dynamic, which explains various factors responsible for future growth, challenges and opportunities for Japan In vitro Diagnostics.
Porter's Five Forces Analysis
In this report, we provide in-depth analysis of all five forces and their significant impact on market supply and demand of Japan In-vitro Diagnostic products.
Renub Research report titled “Japan In–Vitro Diagnostics (IVD) Market, By Diagnostics (Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring of Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Roche Diagnostics, Sysmex Corporation, Abbott Laboratories & Others), Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities)” provides a complete analysis of Japan In–Vitro Diagnostics (IVD) Market.
By Segment
1. Urine & Feces
2. Hematology
3. Clinical Chemistry
4. Self Monitoring of Blood Glucose (SMBG)
5. Tumor Marker
6. Immunology
7. Infectious disease
8. Microbiology
9. Pathology
10. Genetic Testing
11. Others
Company Analysis
Ageing Population will Foster the Growth of Japan In vitro Diagnostics Market
Japan has highest proportion of ageing population globally; almost its quarter of population is 65+ age. Rise in number of ageing population is the biggest burden for Japanese government because prevalence of ageing disease rising at rapid pace. So Japanese government has given priority to deal with ageing population and it is expected that government will allocate skyrocket healthcare budget in 2025 for ageing. Therefore rising prevalence and increased public expenditure will boost the Japan In Vitro Diagnostics Market in future.
Pathology Market is the Fastest Growing Segment in Japan In-vitro Diagnostics Market
In this report Renub Research has done in-depth study of 11 segments of Japan In-vitro Diagnostic Market: Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology, Genetic Testing and Others. The report gives you comprehensive insight of each segment of In-vitro diagnostic along with separate growth factors for each of segments.
Positive Reimbursement Policy will further boost the Market of Japan In-vitro Diagnostics Market
This report by Renub Research explains length and breadth of reimbursement policies along with complete framework. It also provides clear insight & structure of how it works actually, how to take approval from Japanese authorities regarding reimbursement policies. It explains classification of medical devices in Japan and which class In vitro diagnostic fits. It covers all medical manufacturer applied for reimbursement approval in Japan for past five years.
Continuous Advancement of Diagnostic Technology & non-invasive Technique will improve the Growth of Japan In-vitro Diagnostics Market
The advancement in In vitro Diagnostic technique has made it simpler to diagnose with lesser time being less invasive. The improved digitization in pathology has gain the ability to deliver the clinical outcome within the stipulated time-frame. Japan has successfully done the trial for first urine test to diagnose cancer in the world in 2018. Moreover for colon cancer, screening is conducted via a feces test. All these technology improvement will further enhance the Japan In vitro Diagnostic market.
In this report, we have covered the most important section Market Dynamic, which explains various factors responsible for future growth, challenges and opportunities for Japan In vitro Diagnostics.
Porter's Five Forces Analysis
In this report, we provide in-depth analysis of all five forces and their significant impact on market supply and demand of Japan In-vitro Diagnostic products.
Renub Research report titled “Japan In–Vitro Diagnostics (IVD) Market, By Diagnostics (Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring of Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Roche Diagnostics, Sysmex Corporation, Abbott Laboratories & Others), Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities)” provides a complete analysis of Japan In–Vitro Diagnostics (IVD) Market.
By Segment
1. Urine & Feces
2. Hematology
3. Clinical Chemistry
4. Self Monitoring of Blood Glucose (SMBG)
5. Tumor Marker
6. Immunology
7. Infectious disease
8. Microbiology
9. Pathology
10. Genetic Testing
11. Others
Company Analysis
- Roche Diagnostics
- Abbott Laboratories
- Danaher Corporation
- Biomerieux
1. INTRODUCTION
1.1 Market Definition
1.2 Currency Conversion
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OUTLOOK - JAPAN IN-VITRO DIAGNOSTICS MARKET
5. MARKET SHARE ANALYSIS
6. JAPAN IN-VITRO DIAGNOSTICS MARKET BY SEGMENT
6.1 Urine & Faces Diagnostics
6.2 Hematology
6.3 Clinical Chemistry
6.4 Self-Blood Glucose Monitoring
6.5 Tumor Marker
6.6 Immunology
6.7 Infectious Testing
6.8 Microbiology
6.9 Pathology
6.10 Genetic Testing
6.11 Others
7. PORTER'S FIVE FORCES ANALYSIS
7.1 Threat of New Entry
7.2 The Bargaining Power of Buyer
7.3 Threat of Substitution
7.4 The Bargaining Power of Supplier
7.5 Competitive Rivalry
8. MARKET DYNAMICS
8.1 Growth Drivers
8.2 Challenges
8.3 Opportunities
9. REIMBURSEMENT POLICY
10. ABBOTT LABORATORIES - COMPANY ANALYSIS
10.1 Company Overview
10.2 Company Initiatives
10.2.1 Point
10.2.2 Point
10.2.3 Point
10.3 Financial Insight
11. DANAHER CORPORATION - COMPANY ANALYSIS
11.1 Company Overview
11.2 Company Initiatives
11.2.1
11.2.2
11.3 Financial Insight
12. BIOMERIEUX – COMPANY ANALYSIS
12.1 Company Overview
12.2 Company Initiatives
12.2.1
12.2.2
12.2.3
12.3 Financial Insight
13. ROCHE DIAGNOSTICS – COMPANY ANALYSIS
13.1 Company Overview
13.2 Company Initiatives
13.2.1
13.2.2
13.3 Financial Insight
1.1 Market Definition
1.2 Currency Conversion
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OUTLOOK - JAPAN IN-VITRO DIAGNOSTICS MARKET
5. MARKET SHARE ANALYSIS
6. JAPAN IN-VITRO DIAGNOSTICS MARKET BY SEGMENT
6.1 Urine & Faces Diagnostics
6.2 Hematology
6.3 Clinical Chemistry
6.4 Self-Blood Glucose Monitoring
6.5 Tumor Marker
6.6 Immunology
6.7 Infectious Testing
6.8 Microbiology
6.9 Pathology
6.10 Genetic Testing
6.11 Others
7. PORTER'S FIVE FORCES ANALYSIS
7.1 Threat of New Entry
7.2 The Bargaining Power of Buyer
7.3 Threat of Substitution
7.4 The Bargaining Power of Supplier
7.5 Competitive Rivalry
8. MARKET DYNAMICS
8.1 Growth Drivers
8.2 Challenges
8.3 Opportunities
9. REIMBURSEMENT POLICY
10. ABBOTT LABORATORIES - COMPANY ANALYSIS
10.1 Company Overview
10.2 Company Initiatives
10.2.1 Point
10.2.2 Point
10.2.3 Point
10.3 Financial Insight
11. DANAHER CORPORATION - COMPANY ANALYSIS
11.1 Company Overview
11.2 Company Initiatives
11.2.1
11.2.2
11.3 Financial Insight
12. BIOMERIEUX – COMPANY ANALYSIS
12.1 Company Overview
12.2 Company Initiatives
12.2.1
12.2.2
12.2.3
12.3 Financial Insight
13. ROCHE DIAGNOSTICS – COMPANY ANALYSIS
13.1 Company Overview
13.2 Company Initiatives
13.2.1
13.2.2
13.3 Financial Insight
LIST OF FIGURES
Figure: 1 Japan– In-vitro Diagnostic Market size (Million US$), 2018 & 2024
Figure: 2 Japan– In-vitro Diagnostic Top Two Rapid Growing Segment
Figure: 3 Japan– In-vitro Diagnostic Largest Market Share, Immunology (Percent), 2017 & 2024
Figure: 4 Japan– In-vitro Diagnostics Market (Million US$), 2008 – 2017
Figure: 5 Japan– Forecast for In-vitro Diagnostics Market (Million US$), 2018 – 2024
Figure: 6 Japan– Urine & Faces Diagnostics Market (Million US$), 2008 – 2017
Figure: 7 Japan– Forecast for Urine & Faces Diagnostics Market (Million US$), 2018 – 2024
Figure: 8 Japan– Hematology Market (Million US$), 2008 – 2017
Figure: 9 Japan– Forecast for Hematology Market (Million US$), 2018 – 2024
Figure: 10 Japan– Clinical Chemistry Market (Million US$), 2008 – 2017
Figure: 11 Japan– Forecast for Clinical Chemistry Market (Million US$), 2018 – 2024
Figure: 12 Japan– SMBG Market (Million US$), 2008 – 2017
Figure: 13 Japan– Forecast for SMBG Market (Million US$), 2018 – 2024
Figure: 14 Japan– Tumor Marker Market (Million US$), 2008 – 2017
Figure: 15 Japan– Forecast for Tumor Marker Market (Million US$), 2018 – 2024
Figure: 16 Japan– Immunology Market (Million US$), 2008 – 2017
Figure: 17 Japan– Forecast for Immunology Market (Million US$), 2018 – 2024
Figure: 18 Japan– Infectious Disease Market (Million US$), 2008 – 2017
Figure: 19 Japan– Forecast for Infectious Disease Market (Million US$), 2018 – 2024
Figure: 20 Japan– Microbiology Testing Market (Million US$), 2008 – 2017
Figure: 21 Japan– Forecast for Microbiology Testing Market (Million US$), 2018 – 2024
Figure: 21 Japan– Pathology Market (Million US$), 2008 – 2017
Figure: 22 Japan– Forecast for Pathology Market (Million US$), 2018 – 2024
Figure: 23 Japan– Genetic Testing Market (Million US$), 2008 – 2017
Figure: 24 Japan– Forecast for Genetic Testing Market (Million US$), 2018 – 2024
Figure: 25 Japan– Others Market (Million US$), 2008 – 2017
Figure: 26 Japan– Forecast for Others Market (Million US$), 2018 – 2024
Figure: 27 Abbott Laboratories – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure: 28 Abbott Laboratories – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure: 29 Danaher Corporation – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure: 30 Danaher Corporation – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure: 31 Biomerieux – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure: 32 Biomerieux – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure: 33 Roche Diagnostics – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure: 34 Roche Diagnostics – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure: 1 Japan– In-vitro Diagnostic Market size (Million US$), 2018 & 2024
Figure: 2 Japan– In-vitro Diagnostic Top Two Rapid Growing Segment
Figure: 3 Japan– In-vitro Diagnostic Largest Market Share, Immunology (Percent), 2017 & 2024
Figure: 4 Japan– In-vitro Diagnostics Market (Million US$), 2008 – 2017
Figure: 5 Japan– Forecast for In-vitro Diagnostics Market (Million US$), 2018 – 2024
Figure: 6 Japan– Urine & Faces Diagnostics Market (Million US$), 2008 – 2017
Figure: 7 Japan– Forecast for Urine & Faces Diagnostics Market (Million US$), 2018 – 2024
Figure: 8 Japan– Hematology Market (Million US$), 2008 – 2017
Figure: 9 Japan– Forecast for Hematology Market (Million US$), 2018 – 2024
Figure: 10 Japan– Clinical Chemistry Market (Million US$), 2008 – 2017
Figure: 11 Japan– Forecast for Clinical Chemistry Market (Million US$), 2018 – 2024
Figure: 12 Japan– SMBG Market (Million US$), 2008 – 2017
Figure: 13 Japan– Forecast for SMBG Market (Million US$), 2018 – 2024
Figure: 14 Japan– Tumor Marker Market (Million US$), 2008 – 2017
Figure: 15 Japan– Forecast for Tumor Marker Market (Million US$), 2018 – 2024
Figure: 16 Japan– Immunology Market (Million US$), 2008 – 2017
Figure: 17 Japan– Forecast for Immunology Market (Million US$), 2018 – 2024
Figure: 18 Japan– Infectious Disease Market (Million US$), 2008 – 2017
Figure: 19 Japan– Forecast for Infectious Disease Market (Million US$), 2018 – 2024
Figure: 20 Japan– Microbiology Testing Market (Million US$), 2008 – 2017
Figure: 21 Japan– Forecast for Microbiology Testing Market (Million US$), 2018 – 2024
Figure: 21 Japan– Pathology Market (Million US$), 2008 – 2017
Figure: 22 Japan– Forecast for Pathology Market (Million US$), 2018 – 2024
Figure: 23 Japan– Genetic Testing Market (Million US$), 2008 – 2017
Figure: 24 Japan– Forecast for Genetic Testing Market (Million US$), 2018 – 2024
Figure: 25 Japan– Others Market (Million US$), 2008 – 2017
Figure: 26 Japan– Forecast for Others Market (Million US$), 2018 – 2024
Figure: 27 Abbott Laboratories – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure: 28 Abbott Laboratories – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure: 29 Danaher Corporation – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure: 30 Danaher Corporation – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure: 31 Biomerieux – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure: 32 Biomerieux – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
Figure: 33 Roche Diagnostics – Global In-vitro Diagnostic Sales (Million US$), 2015 - 2017
Figure: 34 Roche Diagnostics – Global Forecast for In-vitro Diagnostic Sales (Million US$), 2018 - 2024
LIST OF TABLES
Table: 01 Japan – In-vitro Diagnostics Market Share (Percent), 2008 – 2017
Table: 02 Japan – Forecast for In-vitro Diagnostics Market Share (Percent), 2018 – 2024
Table: 03 Japan– Medical Device Classification
Table: 04 New reimbursement evaluated between October 31, 2012, to November 22, 2017
Table: 01 Japan – In-vitro Diagnostics Market Share (Percent), 2008 – 2017
Table: 02 Japan – Forecast for In-vitro Diagnostics Market Share (Percent), 2018 – 2024
Table: 03 Japan– Medical Device Classification
Table: 04 New reimbursement evaluated between October 31, 2012, to November 22, 2017
